花旗降会德丰(0020.HK)目标价至56.8港元维持“买入”评级
花旗报告指会德丰(00020.HK)受惠于香港项目销售率高,未入帐收入高达350亿元,该行预期公司已锁定2019年全年(Oasis Kai Tak)、2020年全年(Malibu)及2021年部分(Montara & Grand Montara)香港物业销售收入。

此外,公司计划下半年将推售日出康城第9期项目(1,653伙),该行预期将再次吸引强劲购买力。该行维持会德丰“买入”评级,惟目标价由73.7港元降至56.8港元,以反映净资产值下降(九仓(00004.HK)及九仓置业(01997.HK)目标价较低),及因宏观/本地逆风而给予较大净资产值折让等因素。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.